The Arabidopsis resistance protein RPS5 is activated by proteolytic 26 cleavage of the protein kinase PBS1 by the Pseudomonas syringae effector 27 42 extended this PBS1 decoy approach to soybean by modifying a soybean PBS1 43 ortholog to be cleaved by the NIa protease of soybean mosaic virus (SMV). 44 Transgenic overexpression of this soybean PBS1 decoy conferred immunity to 45 SMV, demonstrating that we can use endogenous PBS1 proteins in crop plants to 46 engineer economically relevant disease resistant traits. 47 48 3 S. Pottinger BioRxiv 129 130
protease AvrPphB. We have previously shown that replacing seven amino acids 28 at the cleavage site of PBS1 with a motif cleaved by the NIa protease of turnip 29 mosaic virus (TuMV) enables RPS5 activation upon TuMV infection. However, this 30 engineered resistance conferred a trailing necrosis phenotype indicative of a cell 31 death response too slow to contain the virus. We theorized this could result from 32 a positional mismatch within the cell between PBS1 TuMV , RPS5 and the NIa 33 protease. To test this, we re-localized PBS1 TuMV and RPS5 to cellular sites of NIa 34 accumulation. These experiments revealed that relocation of RPS5 away from the 35 plasma membrane compromised RPS5-dependent cell death in N. benthamiana, 36 even though PBS1 was efficiently cleaved. As an alternative approach, we tested 37 whether overexpression of plasma membrane-localized PBS1 TuMV Innes 1995) . AvrPphB is a cysteine protease that targets serine-threonine kinases 54 involved in pathogen-associated molecular pattern (PAMP)-triggered immunity 55 (Zhang et al. 2010 ; Shao et al. 2003) . One of these kinases, PBS1, forms a 56 preactivation complex with RPS5 and triggers RPS5 activation upon AvrPphB-57 dependent cleavage (Ade et al. 2007 ). It is the resulting conformational change in 58 PBS1 that activates RPS5, rather than the cleavage itself, as shown by the 59 observation that insertion of three alanine residues into the cleavage loop of PBS1 60 is sufficient to activate RPS5 in the absence of cleavage (DeYoung et al. 2012). 61 Therefore, RPS5 can theoretically confer resistance to any pathogen with an 62 effector capable of causing the necessary conformational change in PBS1. 63 The work presented here follows on from that published in Kim et al. 2016 64 in which novel resistance to Turnip mosaic virus (TuMV) was engineered by 65 insertion of a cleavage motif for the NIa protease of TuMV into PBS1 (PBS1 TuMV ). 66 However, the engineered resistance was not complete, as transgenic PBS1 TuMV 67 Arabidopsis plants displayed a trailing necrosis phenotype. This suggests the 68 immune response produced by this engineered resistance was too slow to prevent 69 the spread of viral infection (Kim et al. 2016) . We theorized this could be due to a 70 positional mismatch within the cell between the PBS1/RPS5 complex and the viral 71 protease. Both PBS1 and RPS5 are tethered to the plasma membrane, along with 72 AvrPphB Dowen et al. 2009 ). However, the TuMV NIa protease is 73 primarily located at the endoplasmic reticulum and in the nucleus (Cotton et al. 74 2009; Restrepo et al. 1990 ), raising the possibility that PBS1 TuMV is only cleaved 75 late in the infection process, once high levels of viral proteins have accumulated 76 and neighboring cells have already been infected. To test this hypothesis, we used 77 genetic techniques to relocate the PBS1 TuMV -RPS5 complex to regions of NIa 78 accumulation and then assessed for improved activation of RPS5. We also tested 79 whether overexpression of plasma membrane-localized PBS1 TuMV could enhance 80 4 S. Pottinger BioRxiv resistance. These experiments revealed that whilst the localization of PBS1 TuMV 81 does not affect its ability to be cleaved by NIa protease, RPS5 is unable to induce 82 cell death, unless it is located at the plasma membrane. However, overexpression 83 of plasma membrane localized PBS1 TuMV conferred complete resistance to TuMV 84 systemic infection, eliminating the trailing necrosis phenotype. We also show that 85 the PBS1 decoy system can be deployed in crop plants, as transgenic 86 overexpression of a soybean PBS1 protein engineered to be cleavable by the NIa 87 protease of soybean mosaic virus (SMV) conferred immunity to SMV in soybean. 88 Because the PBS1 gene is highly conserved across angiosperms (Caldwell and 89 Michelmore, 2009), this last finding has broad implications for engineering novel 90 disease resistance traits in crops. 
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To test whether the PBS1/RPS5 system remains functional when not at the 98 plasma membrane, we modified acylation motifs present in the N-termini of RPS5 99 and PBS1, which anchor these proteins to the plasma membrane (PM) (Qi et al. which the exception of RPS5-NLS, whose localization remained more cytoplasmic. 112 The cytoplasmic (Cyt.) PBS1 TuMV -sYFP construct produced a strong cytoplasmic 113 accumulation as well as accumulation in the nucleus. However, cytoplasmic 114 RPS5-sYFP accumulated to much lower levels ( Fig. 1) , consistent with the 115 reduced stability of the RPS5 G2/3A,C4A -sYFP construct that has been published 116 previously ). 117 To more fully match the localization of the PBS1/RPS5 complex to sites of 118 viral replication, the acylation sites of PBS1 TuMV and RPS5 were replaced with the 119 complete TuMV 6K2 protein sequence. Under conditions of viral infection, the 6K2 120 protein has been shown to manipulate host endomembranes into viral 'replication 121 factories' (Cotton et al. 2009 ). We predicted that fusion of the 6K2 protein to the 122 N-termini of PBS1 TuMV and RPS5 would localize them to these viral replication 123 factories during infection, and possibly to ER-derived structures in the absence of 124 virus. The 6K2-PBS1 TuMV -sYFP accumulated on the surface of chloroplasts and 125 caused chloroplasts to clump ( Fig. 1 and Supplementary Fig. S1 ) as has been 126 previously shown for 6K2-YFP (Wei et al. 2010 ). 6K2-RPS5-sYFP accumulated 127 in vesicle-like puncta within the cytoplasm (Fig. 1 150 Having confirmed that re-localized PBS1 TuMV -HA is efficiently cleaved by 151 the TuMV NIa protease, we next tested whether co-localized PBS1 TuMV and RPS5 152 could still activate programmed cell death when transiently co-expressed in N. 3A). However, none of the re-localized RPS5/PBS1 TuMV complexes were able to 156 do so ( Fig. 3A ), suggesting that RPS5 may not function in these locations. 157 Immunoblot analyses revealed that the relocalized RPS5 constructs accumulated 158 to levels similar to that of PM-localized RPS5, with the exception of 6K2-RPS5, 159 which was lower ( Fig. 3B ). Thus, the lack of cell death induction was unlikely due 160 to insufficient levels of RPS5. 161 To confirm that the lack of cell death was due to an inability of re-localized 162 RPS5 to signal from locations other than the PM, we used an auto-active mutant phenotype. We thus tested each modified PBS1 TuMV construct for activation of 176 wild-type RPS5; however, only the 6K2-PBS1 TuMV construct showed a cell death 177 response (Fig. 3A) . These results indicate that re-localization of PBS1 away from 178 the PM eliminates its ability to activate RPS5-dependent HR, with the exception of 179 the 6K2-PBS1 TuMV construct. Notably, this is the construct that localized around 180 the periphery of chloroplasts ( Fig. 1 and Supplementary Fig. S1 ), and perhaps 181 reflects the close association of chloroplasts with the PM. Overexpression of a soybean PBS1 decoy protein, GmPBS1-1 SMV , in soybean 255 confers immunity to soybean mosaic virus. 256 We have recently shown that PBS1 proteins from soybean can also be 257 engineered to confer recognition of the NIa protease from SMV and that cleavage 258 of these decoy proteins activates cell death in soybean protoplasts, suggesting the 259 decoy engineering approach can be extended to a crop plant (Helm et al., 2019). 260 It was unclear, however, whether transgenic soybean expressing the GmPBS1-261 1 SMV decoy protein would confer resistance to SMV. We thus generated transgenic The above experiments show that the PBS1 decoy system is capable of 284 conferring complete resistance to a viral pathogen. We have also shown that 285 plasma membrane localization is not essential for stable accumulation of 286 PBS1 TuMV , nor is it necessary for cleavage of PBS1 TuMV by the TuMV NIa protease. 287 We have also shown that although cytosolic RPS5 is unstable, targeting to it to 288 other cellular compartments can stabilize it. However, away from the plasma 289 membrane, RPS5 cannot activate cell death, even when constitutively active. Arabidopsis genome encodes many putative NLR proteins with degenerate P-349 loops, suggesting a widespread role for helper NLR proteins. 350 Elucidating the signaling mechanism used by RPS5 would shed light on 351 whether the direct pore mechanism proposed for ZAR1 is a common signaling 352 mechanism used by CC-NLRs, or whether the scaffolding mechanism used by 353 mammalian NLRs is also present in plants. In either case, it could be that the Supplementary Table S1 ). In addition, the forward primers were designed to Supplementary Table   452 S1, and all constructs generated are listed in Supplementary Table S2 . 453 To generate the pWI-1000:E35S::GmPBS1-1 SMV -HA construct, GmPBS1- Beta-meracptoethanol, 1 mL 1.5M NaCl, 7.8 mL water, 1 tablet of EDTA-free 613 Complete protease inhibitor cocktail) was added directly to the frozen tissue and 614 mixed until homogeneous at room temperature (1 mg tissue:2 µL buffer). After 615 mixing, samples were boiled for 10 minutes and cell debris pelleted in a microfuge 616 at 15,000 RPM for 10 minutes at room temperature. Supernatants were mixed with 617 loading buffer in a 1:1 ratio before separation at 70V for 15 minutes then 90V for 
